About SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal
During the past decade, SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
2009-09-01
2011-09-01
Completed
74,256
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V
2010-06-01
2010-09-01
Completed
1,200
Rib Fixation for Clinically Severe Rib Fractures From Trauma
2015-04-01
2023-12-01
Recruiting
236
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
2016-04-26
2023-12-01
Active, not recruiting
271
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal
According to Clinical.Site data, the most researched conditions in "SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal" are
"Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal" in a lesser frequency.
Clinical Trials Intervention Types at SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal
Most popular intervention types in "SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Cisplatin" (1 trials), "Docetaxel" (1 trials), "Gemcitabine" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal
The vast majority of trials in "SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal" are
2 trials for "All" genders.
Clinical Trials Status at SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal
Currently, there are NaN active trials in "SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SLK Kliniken Heilbronn GmbH, Standort Fachklinik Löwenstein; Onk & Pal, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".